Stemming the tide of river blindness: The early years of ivermectin

Medical Journal of Australia

Volumn 179, Issue 11-12, 2003, Pages 617-619

  Taylor, Hugh R ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Ringland Anderson   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLCARBAMAZINE; IVERMECTIN; LARVICIDAL AGENT; NEW DRUG; PLACEBO; SURAMIN;

AFRICA; CLINICAL TRIAL; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG TOXICITY; DRUG USE; ENDEMIC DISEASE; FILARIASIS; HUMAN; LIFE CYCLE; NONHUMAN; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; OPHTHALMOLOGY; PARASITE CONTROL; PARASITE TRANSMISSION; REVIEW; SIDE EFFECT; SIMULIUM DAMNOSUM; TRYPANOSOMIASIS; WORLD HEALTH ORGANIZATION;

EID: 0348038810     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05720.x     Document Type: Review

References (19)

1. Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control. World Health Organ Tech Rep Ser 1995; 852: 1-104.
2. Hewitt RI, White DE, Jushner S, et al. Piperazines in the treatment of filariasis. Ann N Y Acad Sci 1948; 50: 128-140.
3. Mazzotti L. Possibility of using the allergic reactions due to the administration of Hetrazan as an auxiliary diagnostic test for onchocerciasis. Revista del Instituto del Salubridad y Enfermedades Tropicales 1948; 9: 235-237.
4. Hawking F. Suramin: With special reference to onchocerciasis. Adv Pharm Chemother 1978; 15: 289-322.
5. Campbell WC. Invermectin and Abamectin. New York: Springer-Verlag, 1989.
6. Aziz MA, Diallo S, Diop IM, et al. Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet 1982; 2: 70-78.
7. Greene BM, Taylor HR, Cupp EW, et al. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. N Engl J Med 1985; 313: 133-138.
8. Larivieri M, Vingtain P, Aziz M, et al. Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement. Lancet 1985; 2: 174-177.
9. Awadzi K, Dadzie KY, Schulz-Key H, et al. The chemotherapy of onchocerciasis. XI: A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana. Ann Trop Med Parasitol 1986; 80: 433-442.
10. White AT, Newland HS, Taylor HR, et al. Controlled trial and dose-finding study of ivermectin for treatment of onchocerciasis. J Infect Dis 1987; 156: 463-470.
11. Newlands HS, White AT, Green BM, et al. Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement. Br J Ophthalmol 1988; 72: 561-569.
12. Lindley D. Merck's new drug free to WHO for river blindness programme. Nature 1987; 329: 752.
13. Pacque MC, Dukuly Z, Greene BM, et al. Community-based treatment of onchocerciasis with ivermectin: Acceptability and early adverse reactions. Bull World Health Organ 1989; 67: 721-730.
14. Pacque M, Munoz B, Poetschke G, et al. Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution. Lancet 1990; 336: 1486-1489.
15. Taylor HR, Pacque M, Munoz B, Greene BM. Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection. Science 1990; 250: 116-118.
16. Taylor HR, Gonzalas C, Duke B. Simplified dose schedule of ivermectin. Lancet 1993; 341: 50-51.
17. Dull HB, Meredith SEP. The Mectizan Donation Programme - A 10-year report. Ann Trop Med Parasitol 1998; 92 Suppl 1: S69-S71.
18. Richards R. Programmatic goals and approaches to onchocerciasis. Lancet 2000; 355: 1663-1664.
19. Dadzie KY, VanNewkirk MR, Taylor HR. Onchocerciasis. In: Denny M, Wallach RS, Dondrea CL, editors. International Ophthalmology 2002-2003. San Francisco: American Academy of Ophthalmology, 2002: 231-246.